Abatacept + Placebo matching with Abatacept + Methotrexate
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Rheumatoid Arthritis
Conditions
Rheumatoid Arthritis
Trial Timeline
Apr 11, 2013 → Dec 26, 2016
NCT ID
NCT01758198About Abatacept + Placebo matching with Abatacept + Methotrexate
Abatacept + Placebo matching with Abatacept + Methotrexate is a approved stage product being developed by Ono Pharmaceutical for Rheumatoid Arthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT01758198. Target conditions include Rheumatoid Arthritis.
What happened to similar drugs?
20 of 20 similar drugs in Rheumatoid Arthritis were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01758198 | Approved | Completed |
Competing Products
20 competing products in Rheumatoid Arthritis